These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7880840)

  • 1. Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue.
    Brauns T; Cai ZW; Kimball SD; Kang KC; Haugland RP; Berger W; Berjukov S; Hering S; Glossmann H; Striessnig J
    Biochemistry; 1995 Mar; 34(10):3461-9. PubMed ID: 7880840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other.
    Brauns T; Prinz H; Kimball SD; Haugland RP; Striessnig J; Glossmann H
    Biochemistry; 1997 Mar; 36(12):3625-31. PubMed ID: 9132014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex molecular mechanism for dihydropyridine binding to L-type Ca(2+)-channels as revealed by fluorescence resonance energy transfer.
    Berger W; Prinz H; Striessnig J; Kang HC; Haugland R; Glossmann H
    Biochemistry; 1994 Oct; 33(39):11875-83. PubMed ID: 7918406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique fluorescent phenylalkylamine probe for L-type Ca2+ channels. Coupling of phenylalkylamine receptors to Ca2+ and dihydropyridine binding sites.
    Knaus HG; Moshammer T; Kang HC; Haugland RP; Glossmann H
    J Biol Chem; 1992 Feb; 267(4):2179-89. PubMed ID: 1310311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo labeling of L-type Ca2+ channels by fluorescent dihydropyridines: evidence for a functional, extracellular heparin-binding site.
    Knaus HG; Moshammer T; Friedrich K; Kang HC; Haugland RP; Glossman H
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3586-90. PubMed ID: 1314393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of benz(othi)azepine-binding regions within L-type calcium channel alpha1 subunits.
    Kraus R; Reichl B; Kimball SD; Grabner M; Murphy BJ; Catterall WA; Striessnig J
    J Biol Chem; 1996 Aug; 271(33):20113-8. PubMed ID: 8702733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent probing with felodipine of the dihydropyridine receptor and its interaction with the ryanodine receptor calcium release channel.
    Minarovic I; Mészáros LG
    Biochem Biophys Res Commun; 1998 Mar; 244(2):519-24. PubMed ID: 9514900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
    Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
    Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.
    Kimball SD; Floyd DM; Das J; Hunt JT; Krapcho J; Rovnyak G; Duff KJ; Lee VG; Moquin RV; Turk CF
    J Med Chem; 1992 Feb; 35(4):780-93. PubMed ID: 1311765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
    Knaus HG; Striessnig J; Hering S; Marrer S; Schwenner E; Höltje HD; Glossmann H
    Mol Pharmacol; 1992 Feb; 41(2):298-307. PubMed ID: 1311409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels.
    Hering S; Savchenko A; Strübing C; Lakitsch M; Striessnig J
    Mol Pharmacol; 1993 May; 43(5):820-6. PubMed ID: 8388993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
    Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil.
    Kimball SD; Hunt JT; Barrish JC; Das J; Floyd DM; Lago MW; Lee VG; Spergel SH; Moreland S; Hedberg SA
    Bioorg Med Chem; 1993 Oct; 1(4):285-307. PubMed ID: 8081860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of dihydropyridine (DHP) binding sites on cultured monkey renal cells (GMRC) with a photoaffinity probe (-)-[3H]-azidopine.
    Drímal J
    Gen Physiol Biophys; 1994 Apr; 13(2):137-48. PubMed ID: 7528701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benzazepine/benzothiazepine binding domain of the cardiac L-type Ca2+ channel is accessible only from the extracellular side.
    Seydl K; Kimball D; Schindler H; Romanin C
    Pflugers Arch; 1993 Sep; 424(5-6):552-4. PubMed ID: 8255741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.
    Ballesta JJ; Garcia AG; Gutierrez LM; Hidalgo MJ; Palmero M; Reig JA; Viniegra S
    Br J Pharmacol; 1990 Sep; 101(1):21-6. PubMed ID: 1704272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-induced accelerated dissociation of (+)-cis-diltiazem from L-type Ca2+ channels is simply explained by competition for individual attachment points.
    Prinz H; Striessnig J
    J Biol Chem; 1993 Sep; 268(25):18580-5. PubMed ID: 8395510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.